Brief: Amphastar Pharmaceuticals Inc - Authorizes $50 Million Increase To Share Buyback Program On March 12, 2026 - SEC Filing
March 16 (Reuters) - Amphastar Pharmaceuticals Inc AMPH.O: AMPHASTAR PHARMACEUTICALS INC - AUTHORIZES $50 MILLION INCREASE TO SHARE BUYBACK PROGRAM ON MARCH 12, 2026 - SEC FILING Source text: [ID:n0001104659-26-027814] Further company coverage: AMPH.O ((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Amphastar Pharmaceuticals,
See all newsU.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
Amphastar Q1 revenue and adjusted EPS miss estimates
Brief: Amphastar Pharmaceuticals Q1 EPS USD 0.14
Brief: Amphastar Pharmaceuticals Inc - Authorizes $50 Million Increase To Share Buyback Program On March 12, 2026 - SEC Filing
Brief: Amphastar Pharmaceuticals- Nanjing Pharmaceuticals Enters Supply Agreement With Nanjing Letop Biotechnology On March 3 - SEC Filing